ECONOMIC EVALUATION OF LENALIDOMIDE IN THE TREATMENT OF LOWER RISK MYELODYSPLASTIC SYNDROMES WITH DEL5Q (MDS DEL5Q) IN MEXICO
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1064
https://www.valueinhealthjournal.com/article/S1098-3015(16)01132-3/fulltext
Section Title :
Systemic Disorders/Conditions - Cost Studies
Section Order :
909
First Page :
A248
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01132-3&doi=10.1016/j.jval.2016.03.1064